D-1001-2019 Class II Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Princeton, NJ

FDA drug recall D-1001-2019 was initiated by Dr. Reddy's Laboratories, Inc. on Mar 6, 2019 and is designated Class II. Reason for recall: Defective Container: complaint for seal and cap vial issues that could lead to a lack of sterility assurance. The recall status is terminated (terminated May 16, 2022). Affected quantity: 5,755 vials.

Recall details

Product Type
Drugs
Report Date
Mar 20, 2019
Initiation Date
Mar 6, 2019
Termination Date
May 16, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5,755 vials

Product description

Docetaxel Injection USP, 80 mg/4 mL, (20 mg/mL), One-Vial Formulation, Rx only, Mfd By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046, Andhra Pradesh, INDIA, NDC 43598-259-40.

Reason for recall

Defective Container: complaint for seal and cap vial issues that could lead to a lack of sterility assurance.

Distribution pattern

Nationwide in the USA

Code information

Lot#: H7081, Exp 07/2019

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1001-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1001-2019. Report a data issue: hello@regdatalab.com.